Lineage Cell Therapeutics, Inc. 13D and 13G filings for ASTERIAS BIOTHERAPEUTICS, INC.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-08 5:00 pm Sale |
2021-01-07 | 13D | ASTERIAS BIOTHERAPEUTICS, INC. AST |
Lineage Cell Therapeutics Inc. LCTX |
3,297,401 4.900% |
-968,503 (-22.70%) |
Filing |
| 2020-04-27 5:28 pm Sale |
2020-04-23 | 13D | ASTERIAS BIOTHERAPEUTICS, INC. AST |
Lineage Cell Therapeutics Inc. LCTX |
4,265,904 6.300% |
-1,775,250 (-29.39%) |
Filing |